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Background: We sought to evaluate the effect of application of the revised 2010 Task Force Criteria (TFC) on the
prevalence of major and minor Cardiovascular Magnetic Resonance (CMR) criteria for Arrhythmogenic Right
Ventricular Cardiomyopathy (ARVC) versus application of the original 1994 TFC. We also assessed the utility of MRI
to identify alternative diagnoses for patients referred for ARVC evaluation.
Methods: 968 consecutive patients referred to our institution for CMR with clinical suspicion of ARVC from 1995 to
2010, were evaluated for the presence of major and minor CMR criteria per the 1994 and 2010 ARVC TFC. CMR
criteria included right ventricle (RV) dilatation, reduced RV ejection fraction, RV aneurysm, or regional RV wall
motion abnormalities. When quantitative measures of RV size and function were not available, and in whom
abnormal size or function was reported, a repeat quantitative analysis by 2 qualified CMR physicians in consensus.
Results: Of 968 patients, 220 (22.7%) fulfilled either a major or a minor 1994 TFC, and 25 (2.6%) fulfilled any of the
2010 TFC criterion. Among patients meeting any 1994 criteria, only 25 (11.4%) met at least one 2010 criterion. All
patients who fulfilled a 2010 criteria also satisfied at least one 1994 criterion. Per the 2010 TFC, 21 (2.2%) patients
met major criteria and 4 (0.4%) patients fulfilled at least one minor criterion. Eight patients meeting 1994 minor
criteria were reclassified as satisfying 2010 major criteria, while 4 patients fulfilling 1994 major criteria were
reclassified to only minor or no criteria under the 2010 TFC.
Eighty-nine (9.2%) patients had alternative cardiac diagnoses, including 43 (4.4%) with clinically significant potential
ARVC mimics. These included cardiac sarcoidosis, RV volume overload conditions, and other cardiomyopathies.
Conclusions: Application of the 2010 TFC resulted in reduction of total patients meeting any diagnostic CMR
criteria for ARVC from 22.7% to 2.6% versus the 1994 TFC. CMR identified alternative cardiac diagnoses in 9.2% of
patients, and 4.4% of the diagnoses were potential mimics of ARVC.
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Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
is a rare autosomal dominant disorder that frequently
manifests as ventricular tachycardia or sudden cardiac
death in young patients. Histopathologically, it is char-
acterized by progressive fibro-fatty replacement of the
myocardium, leading to right ventricular dysfunction
[1-5] and ventricular ectopy. Early diagnosis of ARVC is
considered imperative for prognosis and management,
which usually consists of implantation of an automatic
implantable defibrillator. Definitive diagnosis of ARVC
remains challenging due to a low disease prevalence
and the lack of a single conclusive diagnostic test [6].
Per the 1994 task force criteria (TFC) of the European
Society of Cardiology and of the Scientific Council on
Cardiomyopathies of the International Society and
Federation of Cardiology, a clinical diagnosis of ARVC
is established on the basis of structural and functional
alteration, electrocardiographic abnormalities, and a
positive family history [7].
Cardiovascular magnetic resonance (CMR) has shown
promise in the evaluation of patients with suspected
ARVC, given its ability to provide highly accurate ana-
tomical and functional information [8-14]. In 2010,
TFC formally incorporated CMR findings (such as the
presence of regional wall motion abnormalities and
quantitative functional assessment) into the diagnostic
criteria for ARVC [15]. The presence of fatty myocar-
dial infiltration by CMR, which was initially thought to
be important in the diagnosis of ARVC due to its
unique pathological process, is included in neither the
1994 nor 2010 TFC due to its high prevalence in the
normal aging patient population [16-18]. Vermes et al.
have found that the 2010 TFC resulted in a higher spe-
cificity but a lower sensitivity in identifying patients
with ARVC, compared to the 1994 TFC [19]. However,
the utility of the 2010 imaging criteria has not been
validated in large cohorts.
In this study, we sought to evaluate the effect of re-
vised 2010 Task Force Criteria (TFC) on the prevalence
of major and minor CMR criteria for ARVC versus the
1994 TFC with and without the presence of fatty infil-
trate and abnormal Late Gadolinium Enhancement
(LGE) as an additional criterion. In addition, we assessed
the utility of CMR in identifying alternative diagnoses
for patients referred for ARVC evaluation.Methods
Our institutional IRB granted a waiver for this retro-
spective research. HIPAA compliance was maintained
throughout the study. No outside funding was re-
ceived, and the authors maintained full control over
the data.Study population
This retrospective cohort study consisted of 968 consecu-
tive patients who were referred to our institution for CMR
with clinical suspicion of ARVC between 1995 and 2010.
Baseline characteristics including age, gender, height, and
weight were extracted from clinical CMR reports and
electronic medical records.
CMR protocol
All CMR exams were performed on a 1.5 Tesla field
strength scanner (Signa Excite HDXt platform, General
Electric Healthcare, Milwaukee, USA) using a dedicated
8-channel cardiac coil with technical parameters recom-
mended by the manufacturer and optimized on a case-by-
case basis via direct physician supervision. After localizing
images were obtained, high-resolution T1-weighted spin-
echo images were acquired in an axial plane through the
ventricles, followed by corresponding fat-suppressed T1
spin-echo images. Double inversion recovery fast spin echo
T1 images were acquired with and without fat satur-
ation in the short axis plane. Cine balanced-steady
state free precession (SSFP) cine images were obtained
in short axis, and two-, three- and four-chamber
planes. Late Gadolinium Enhancement (LGE) images
were obtained in the short axis view after intravenous
administration of 0.2 mmol/kg Magnevist (gadopentetate
dimeglumine, Bayer Healthcare Pharmaceuticals, Germany)
with a preparatory null time selected for optimal nulling
of normal myocardium. All quantitative parameters
were measured using balanced-SSFP cine sequences
(short axis view).
CMR image analysis and TFC
The 1994 and 2010 TFC criteria for diagnosis of ARVC
by CMR are detailed in Figure 1.
CMR qualitative parameters for both 1994 and 2010
criteria (assessment of regional wall movement abnor-
malities and presence of RV dilation) were independ-
ently reported by experienced clinical cardiac imagers
(radiologists and cardiologists with at least 5 years of
experience performing and interpreting CMR). Regional
wall motion abnormalities were graded as per standard
department clinical procedures as 1) normal: systolic wall
thickening > 40%; 2) hypokinetic: wall thickening < 40%;
3) akinetic: systolic wall thickening < 10%; 4) dyskinetic:
myocardium that moved outward in systole; 5) aneurysmal:
myocardial segments with persistent bulging in diastole
and outward movement in systole [14].
A flow diagram showed the detailed availability of quan-
titative and qualitative data (Figure 2). When quantitative
measures of RV size and function were not available, and
in whom abnormal size or function was reported, a repeat
quantitative analysis by 2 qualified CMR physicians in
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Figure 1 1994 and 2010 ARVC CMR task force criteria. The flow diagram shows comparison of the details for 1994 and 2010 ARVC
CMR criteria.
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(LVEDV, RVEDV) and LV and RV ejection fraction (LVEF,
RVEF) were calculated using a summation of disks
method (Simpson’s rule) with balanced-SSFP cine im-
ages obtained in the short axis view.
For 1994 TFC, the presence of RV enlargement was
determined per clinical reports when quantitative assess-
ment was not available. Then the severity of global RV
dilation and RVEF reduction was quantitatively deter-
mined according to fixed ranges from the 2010 criteria
[20]. Other qualitative major and minor criteria (presence




Normal RV size or 
function (per reports)
(n=521)
Figure 2 Availability of quantitative and qualitative data. The flow dia
not available. *All the total study cohort (n=968) had qualitative informatio
segmental RV dilatation) per clinical reports.RV dilatation) were identified per clinical reports of all
patients.
For the 2010 TFC, the major and minor criteria were
evaluated based on a combination of severe regional RV
wall movement abnormalities with quantitative assess-
ment of RV volume and function. We first determined
the presence of severe regional RV wall movement ab-
normalities (regional RV akinesia, dyskinesia and con-
tractile dyssynchrony) based on the CMR reports. Then,
quantitative RV measures of end diastolic volume index
(RVEDVI) and RV ejection fraction (RVEF) were evalu-
ated in all patients who determined to have the presenceQualitative only
(n=568)
Abnormal RV size or 
function (per reports)
(n=47)
Quantification of RV 
Size and function by 2 
readers
gram shows how we did in this study when the quantitative data is
n available (segmental RV hypokinesia, dyskinesia, akinesia, aneurysm or
Table 1 Patient Characteristics
Variables No. of patients (n = 968)
Age, years 42 ± 16
Female, n (%) 463 (47.8)
LVEF, % (mean ± SD) 60.2 ± 7.0
RVEF, % (mean ± SD) 52.5 ± 6.8
RVEDVI/BSA, ml/m2(mean ± SD) 86.5 ± 23.3
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chrony, using the equipment and methods detailed
above.
We utilized the 1994 and 2010 TFC for ARVC to adju-
dicate the CMR findings as major, minor or negative. Ac-
cording to the 1994 TFC, localized or generalized severe
RV dilation and dysfunction with normal LV function
were considered major CMR criterion for ARVC. Mild
global RV dilation and dysfunction were interpreted as
minor criterion.
The 2010 TFC for ARVC were applied with respect
to indexed RV size (RVEDVI/BSA, ≥110 ml/m2 for
males and ≥100 ml/m2 for females) or RV function
(RVEF ≤ 40%) as the major CMR-based diagnostic criteria
for ARVD. The milder forms of RV dilation or dysfunction
(RVEDVI/BSA, ≥100 to < 110 ml/m2 for males and ≥ 90
to < 100 ml/m2 for females, RVEF > 40% to ≤ 45%) were
considered as minor criteria.
In addition, all CMR exams were examined for inci-
dental and potential alternative diagnoses. ARVC mimic
diagnoses were categorized into four groups by the type
of abnormality detected, including 1) cardiac displace-
ment, 2) ischemic and/or non-ischemic cardiomyopathy,
3) myocarditis, and 4) RV pressure/volume overload. Fur-
thermore, we recorded the presence of myocardial fat and
LGE as a hypothetical CMR criterion to potentially reclas-




A total of 968 patients between 1995 and 2010 under-
went CMR with tissue characterization for suspected
ARVC. The most common symptom was palpitations
(N = 250, 26%), with others including syncope (N = 124,
13%), chest pain (N = 92, 10%), and shortness of breath
(N = 70, 7%). Baseline EKG showed ST-T wave abnor-
malities in 114 patients, right bundle branch block in 35
patients and left bundle branch block in 20 patients. The
most common medications at the time of exam were
beta-blockers (N = 205) and/or aspirin (N = 128). Cardio-
vascular risk factors were reported in 631 patients,
which included hypertension (N = 156), hyperlipidemia
(N = 136), and history of smoking (N = 158).
The mean age of presentation for CMR analysis was
42 ± 16 years. Overall, Quantitative measures of RV size
and function were available in 406 (42%) of subjects,
while qualitative data were available in the remainder
562 (58%). However, in the subjects where only qualita-
tive data was available, abnormal RV size or function
was reported in 47 patients (Figure 2). Patients had, on
average, preserved LVEF (60.2 ± 7%) and RVEF (52.5 ±
6.8%). The mean RV end-diastolic volume index was
86.5 ± 23.3 cc/m2 (Table 1).1994 and 2010 TFC CMR criteria
Proportional incidence of 1994 and 2010 TFC are re-
ported in Figure 3.
Based on the 1994 TFC, 220 (22.7%) fulfilled either a
major or a minor CMR criterion for ARVC, with 18
(1.9%) fulfilling a major criterion. The majority of these
patients had RV aneurysms followed by severe global RV
dysfunction/dilation. A majority of the patients who ful-
filled a minor criteria did so via regional RV hypokinesis
(N = 133, 13.7%) (Table 2).
Applying the 2010 TFC, only 52 patients were identi-
fied presence of regional RV akinesia, dyskinesia or RV
aneurysms detailed in Table 3; however, almost half of
them fulfilled a major or minor criterion. Contrary to
1994 TFC, relatively fewer patients were identified as
fulfilling minor criteria in 2010 modified TFC.
Among the 220 (22.7%) patients meeting 1994 criteria
for ARVC, only 25 (2.6%) patients satisfied any 2010 cri-
teria (Table 4). Among these 25 patients, 21 met a major
2010 criterion; and 4 fulfilled only minor 2010 criteria.
Conversely, all patients who fulfilled a 2010 criterion for
ARVC also satisfied a 1994 criterion. Eight patients that
met 1994 minor criteria for ARVC were reclassified
since these patients satisfied 2010 major criteria, as de-
termined by severe reduction of RVEF and wall motion
defects but without severe RV dilation or RV aneurysm.
On the other hand, four patients that fulfilled a 1994
major TFC were reclassified to minor criteria or no cri-
teria based on the 2010 TFC, which with the presence of
RV aneurysm but not fulfilled 2010 quantitative criteria
(Table 5). Similar results were founded when we restrict-
ing the cohort to these subjects (n = 406) with complete
quantitative data available, 26.6% met at least a 1994 cri-
terion, while only 2.9% fulfilled 2010 CMR criteria
(Table 6). With inclusion of the presence of any intra-
myocardial fat as an additional, hypothetical criterion,
631 (65%) patients met any 1994 criteria and/or fat cri-
teria versus 550 (57%) patients meeting any 2010 criteria
and/or fat criteria (Table 7).
Among these 220 patients with any CMR 1994 or
2010 criteria, 68 (30.9%) had CMR evidence of LV im-
pairment. Within this subgroup, 6 (2.7%) patients had
LV wall motion abnormality, LV dilatation in 26 (11.8%),
and reduced LVEF in 50 (22.7%) of these patients. 2





Major Minor No Criteria
4
Impact of the 1994 vs. 2010 Task Force Criteria
1994 TFC 2010 TFC
Number of 
patients
Figure 3 Incidence of 1994 and 2010 ARVD criteria. The graph shows the different incidence of patients with major criteria, minor criteria, or
no criteria according to 1994 cardiac magnetic resonance criteria (blue bars) and 2010 criteria (green bars).
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findings
We also examined the presence of other common
cardiac and extra-cardiac findings that could mimic
ARVC (Table 8). Of interest, 16 patients were reported
to have signs of RV pressure or volume overload, with-
out further explanation. Twelve patients had cardio-
myopathy (ischemic or non-ischemic). Other mimics
included cardiac displacement (N = 8), tricuspid regur-
gitation (N = 8), myocarditis (N = 7), cardiac sarcoid-
osis (N = 2), and kyphoscoliosis. Other unexpected
diagnoses that were not directly linked to ARVC but
were detected incidentally included congenital heart
diseases (N = 7), regurgitant valvular diseases (N = 6),
RV lipomatosis (N = 7), coronary anomalies, and LVTable 2 RV function and dimensions based on 1994






Severe global RV dilatation and Reduction of
RVEF
8 0.8
RV aneurysms 12 1.2
Severe segmental RV dilatation 1 0.1
Minor 202 20.9
Mild global RV dilatation 34 3.5
Reduction of RVEF with normal LV 70 7.2
Regional RV hypokinesia 133 13.7
Mild segmental RV dilatation 0 0
Abbreviations: RV right ventricle, RVEF right ventricle ejection fraction,
LV Left ventricle.hypertrophy (Table 9). In total, 89 (9.2%) patients were
found to have an alternative diagnosis rather than
ARVC, 43 (4.4%) of which could mimic ARVC.
Late gadolinium enhancement and ARVC criteria
and mimic
655 subjects underwent LGE imaging, and among these
patients, 132 (20.1%) fulfilled at least a 1994 TFC, while
only 12 (1.8%) met a 2010 TFC. Furthermore, 30 (4.6%)
had positive findings of LGE in the RV, 15 (2.2%) had
LV LGE, and 7 (1.1%) of these patients with both RV and
LV LGE. Among subjects with any 1994 TFC, 16 out of
132 patients were positive for RV LGE. In the patients
with any 2010 TFC, 6 out of 12 patients had RV LGE
(Figure 4). Of the remaining 14 patients with RV LGETable 3 RV function and dimensions based on 2010










RVEDVI/BSA≥ 110 mL/m2 (male)
or ≥ 100 mL/m2 (female)
8/52 15.3
RV ejection fraction, %, <40% 21/52 40.3
Minor 4 4.1
RVEDVI/BSA≥ 100 to < 110 mL/m2(male)
or ≥ 90 to < 100 mL/m2 (female)
1/52 7.6
Abbreviations: RV right ventricle, RWMA regional wall movement abnormality,
RVEF right ventricle ejection fraction, RVEDV/BSA RV end-diastolic volume index to
body surface area.
Table 4 Comparison of 1994 and 2010 MRI criteria
for ARVC
1994 Any TFC or fat None Total
2010
Any TFC or fat 25 0 25
None 195 748 943
Total 220 748 968
Table 6 Comparison of 1994 and 2010 MRI criteria for
ARVC in the quantitative cohort only
1994 Major or minor None Total
2010
Major or minor 12 0 12
None 96 298 394
Total 108 298 406
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cardiac sarcoidosis (positive for both RV and LV LGE),
one patient had a final clinical diagnosis myocarditis,
one patients had ischemic RV infarction, and one had
pulmonic regurgitation and prior ASD; the remaining 9
patients did not have any specific MRI diagnosis but did
have RV LGE. 7 patients with LV LGE also had RV LGE;
all of these met at least one TFC. The other 8 patients
with positive LV LGE all had a final diagnosis which
could mimic ARVC.
Discussion and conclusion
Although ARVC is a rather rare disorder, is a frequent
reason for referral to CMR. In this light, many radiolo-
gists and cardiologists who interpret CMR have become
quite familiar with this relatively uncommon disease en-
tity. According to the 2010 Task Force Criteria, meeting
even a single major criterion (which can be CMR based)
allows for a possible diagnosis of ARVC (the final diagnosis
of which requires further clinical input). Therefore, there
is a significant burden upon cardiac imagers to provide an
accurate assessment and documentation of CMR findings,
as this imaging test may have important repercussions
for clinical management, including the indication for an
implantable cardiac defibrillator placement.
In our study of almost one thousand adult patients
referred for CMR during a 15-year period at a tertiary
academic referral center with the primary indication of
evaluation for ARVC, we report several significant
findings. First, the vast majority of patients (943 out of
968, or 97.4%) undergoing cardiac MRI do not meet
any criteria for ARVC according to the 2010 Task
Force Criteria. This greater selectivity is related to the
introduction of more objective and quantitative param-
eters for diagnosis with the 2010 criteria as comparedTable 5 Comparison of 1994 and 2010 MRI major and
minor criteria for ARVC
1994 Major Minor None Total
2010
Major 13 8 0 21
Minor 1 3 0 4
None 4 191 748 943
Total 18 202 748 968to the 1994 criteria. The low positivity rate of CMR for
ARVC could be considered intuitive given the rarity of
the disease, and may possibly reflect a low threshold
for ordering a CMR to rule out this entity. This finding
becomes important for lower volume centers to recognize,
especially if disease prevalence at their centers is similarly
low or even lower than at our tertiary referral center.
In addition, we have shown that there is significant re-
classification of patients comparing the use of the 1994
versus the 2010 Task Force Criteria. The greatest shift in
classification occurred in those patients who met the
minor criteria according the 1994 Task Force Criteria.
Interestingly, the vast majority of these were re-classified
as having no criteria according to the 2010 criteria, yet 8
patients were upgraded to meeting major criteria. These
findings suggest that the 2010 criteria are “stricter” by
nearly eliminating the category of patients satisfying only
minor criteria. This near dichotomization of cardiac
MRI categorization (into major and no criteria) suggests
a potentially increased importance for CMR in making
the diagnosis of ARVC, as meeting the CMR major cri-
terion allows for a possible diagnosis of ARVC (imaging
findings alone are insufficient for diagnosis). Conversely,
meeting no CMR criteria will eliminate any imaging
criteria contribution to the overall clinical diagnosis of
ARVC, so that significant non-imaging criteria must
therefore be present to establish the diagnosis.
Our findings reinforce and confirm the predictable re-
sults of Vermes et al’ s study by showing an overall reduc-
tion in the prevalence of any positive CMR criteria with
the revised 2010 Task Force guidelines [15,19]. However,
our study included a much larger sample size (968 versus
294 patients), and we included all consecutive patients
referred with an indication of evaluating for ARVC
whereas Vermes et al. only evaluated patients referredTable 7 Comparison of 1994 and 2010 MRI criteria plus
fat for ARVC
1994 Any TFC or fat None Total
2010
Any TFC or fat 25 0 25
None 195 748 943
Total 220 748 968
Table 8 ARVC mimics




Narrow A-P chest diameter 1
Ischemic and non-ischemic cardiomyopathy 12
RV inferior infarction 1
Amylodosis 1





Cardiac inflammatory or infectious disease 7
Myocarditis 7
RV pressure/volume overload disease 16
Pulmonary hypertension 1




Abbreviations: A-P anterior-posterior, RV right ventricle, LVNC left ventricular
non-compaction, ASD atrial septal defect.
Table 9 Other diagnoses and findings from suspected
ARVC patients
Other unexpected diagnoses and findings N
Congenital heart disease 7
Left sided SVC 1
Bicuspid aortic valve 2
Anomalous right coronary artery 3














Right ventricular lipomatosis 6
InteratrialMass 1
Abnormal, but non-pathologic conditions 10
LV hypertrophy 3
Prominent trabeculations 1
Trace pulmonary insufficiency 3
RV hypertrophy 3
Total 46(4.7%)
Abbreviations: SVC superior vena cava, RV right ventricle, LV left ventricle.
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more applicable to a community practice population
(the nature of our referral base made complete electro-
physiology records unavailable in a number of externally
referred patients). A key difference is that although the
number of patients with any positive CMR criteria was
substantially reduced with the 2010 criteria, the number
of patients with major criteria was relatively similar using
both TFC classification schemes. Vermes et al. stated
that their relatively large number of patients meeting
major criteria according to the 1994 criteria was due to
a local tendency to overcall “microaneurysms”, however
this terminology was apparently not described in the
1994 criteria (only aneurysms are discussed). Our readers
tended to use descriptive terminology (e.g. localized bulge
throughout systole and diastole), in addition to the
keyword such as “aneurysm”. In addition, aneurysms
represented a minority of the regional wall motion abnor-
malities that were detected on the examined studies.
Aside from these findings, we have taken a step further
by evaluating two other items of practical importance:
(1) assessing for ARVC “mimics” and other diagnostic
findings, (2) evaluating the value of intra-cardiac fat for
CMR diagnosis of ARVC. Nearly 10% of the patients in
our cohort had either potential ARVC mimics or other
clinically important cardiac diagnoses. These findingsare in accord with the report by Quarta et al. [21].
Although the importance of dedicated CMR sequences
to distinguish between ARVC and cardiac sarcoidosis
and myocarditis have previously been described [22-25],
we found many patients with other cardiomyopathies, as
well as RV volume and pressure overload conditions (atrial
septal defect, tricuspid regurgitation, etc.) that may explain
a patients’ clinical presentation that led to a CMR investi-
gation for ARVC criteria.
Furthermore, much emphasis has historically been
placed on fat assessment of the right ventricular myo-
cardium by CMR, with the inclusion of dedicated fat
suppression sequences for this purpose at many institu-
tions including our own. Traditionally, the conventional
wisdom had been that MRI characterization of fat could
serve as a “pathologic equivalent” and thus meet the
MRI equivalent of the major 1994 TFC (which required














* 2 cardiac sarcoidosis
1 myocarditis
1 pulmonic regurgitation and ASD
Figure 4 Relationships between 1994 and 2010 TFC with LGE. The white box represents all patients with LGE acquired. The blue circle
represents subjects fulfilling 1994 CMR task force criteria. The yellow circle represents subjects fulfilling the 2010 CMR task force criteria. The red
circle shows subjects with the presence of RV late gadolinium enhancement.
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analyzed whether adding the presence of fat in the RV
myocardium as a CMR criterion would provide any
untility in our patient population. As expected, we found
that many patients have some degree of RV myocardial
fat, and that there were no patients not fulfilling 1994
criteria whom would have met 2010 criteria (had RV
myocardial fat been hypothetically included as a criter-
ion). These findings suggest a limited utility for dedicated,
time-intensive sequences for fat evaluation in patients
undergoing CMR evaluation for ARVC.
Lastly, abnormal late gadolinium enhancement imaging
abnormal in contrast-enhanced MRI can be detected in
the right and left ventricular myocardium in patients with
suspected arrhythmogenic right ventricular cardiomyop-
athy suggesting areas of intramyocardial fibrous tissue
[26]. In our study, we found that less than half of the
patients with positive RV LGE also met either the 1994 or
2010 CMR criteria. All the patients with positive LV LGE
but without CMR criteria were ultimately diagnosed
with ARVC mimics. These findings suggest that late
gadolinium enhancement play a very important role in
evaluation of ARVC and is also helpful to identify ARVC
Mimics.
LV involvement of arrhythmogenic right ventricular
has been identified as more common finding in pa-
tients with ARVC. Sen-Chowdhry et al. reported
among 200 affected patients, 76.3% patients were
found with CMR evidence of LV involvement [27]. In
our study, we found 30.9% of the patients with any 1994
or 2010 CMR criteria also had an LV size or function
abnormality.There are, however, several limitations of our retrospect-
ive, imaging-based, study. First, we did not have complete
clinical information for all patients in order to fully assess
clinical Task Force Criteria beyond CMR (e.g. signal-
averaged ECG, Holter monitor, etc.), and therefore, we did
not have a complete “gold standard” for determining a
probable or definitive diagnosis of ARVC. This was sec-
ondary to a wide referral base in which many patients only
came to our center only for CMR, and therefore did not
receive further clinical follow-up at our institution. Sec-
ond, we pooled cases over many years with varying image
quality, during which time technical pulse sequences im-
proved, and clinical readers gained experience. The seg-
mentation of the right ventricle to calculate volumetric
parameters was initially not standardized and in some
older cases was not performed. Manual RV tracing for
quantization is known to be time consuming and to be
operator-dependent [28]. However, our intention was to
include all cases across this time period (which fell be-
tween the 1994 and 2010 TFC, thus eliminating potential
bias due to knowledge of the 2010 TFC) to make our
results more practically applicable. In addition, in our
analysis of ARVC mimics and other cardiac diagnoses,
we did not systematically assess whether CMR was the
first or only test to detect these diagnoses, as some of
these patients may have had additional testing performed
at other institutions that was not accessible to us.
Considerations that could be incorporated into future
guideline documents for CMR imaging of ARVC include
whether other quantitative methods for right ventricular
assessment (e.g. tricuspid annular systolic plane excursion
[TAPSE], time-volume curves [28], phase-contrast MRI
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alternatives to traditional quantification of RV volumes
and functional parameters [30]. Also, long-term clinical
outcome and follow-up data such as defibrillator im-
plantation and appropriate shock therapies, ventricular
arrhythmias, and sudden cardiac death are needed for
these patients to answer questions regarding the efficacy
of current Task Force Criteria in directing further
management.
A minority (2.6%) of clinically suspected ARVC pa-
tients undergoing CMR met the 2010 TFC at our cen-
ter. While this suggests a low diagnostic yield of CMR
for ARVC (and we also noted no additional benefit of
fat assessment), we demonstrated a significantly higher
yield for potential ARVC mimics (cardiomyopathies, RV
volume and pressure overload conditions) at 4.4% [31,32].
Although our results are provocative, a larger, multicenter
registry of CMR for ARVC would be preferable to confirm
our single-center results.
In summary, application of the 2010 TFC resulted in a
reduction of total patients meeting any diagnostic MRI
criteria for ARVC from 22.7% to 2.6% versus application
of the 1994 TFC. The hypothetical inclusion of myocardial
fat as a criterion would not have changed the TFC diagno-
sis in any patients. CMR identified alternative cardiac
diagnoses in 9.1% of patients, and 4.4% of all diagnoses
were potential mimics of ARVC.
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